These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prostate cancer GTV delineation with biparametric MRI and Hearn N; Blazak J; Vivian P; Vignarajah D; Cahill K; Atwell D; Lagopoulos J; Min M Br J Radiol; 2021 Mar; 94(1119):20201174. PubMed ID: 33507812 [TBL] [Abstract][Full Text] [Related]
3. Draulans C; Pos F; Smeenk RJ; Kerkmeijer L; Vogel WV; Nagarajah J; Janssen M; Mai C; Heijmink S; van der Leest M; Zámecnik P; Oyen R; Isebaert S; Maes F; Joniau S; Kunze-Busch M; De Roover R; Defraene G; van der Heide UA; Goffin K; Haustermans K Pract Radiat Oncol; 2021; 11(3):202-211. PubMed ID: 33941347 [TBL] [Abstract][Full Text] [Related]
4. Gross tumor volume delineation in primary prostate cancer on Zhang YN; Lu ZG; Wang SD; Lu X; Zhu LL; Yang X; Fu LP; Zhao J; Wang HF; Xiang ZL Cancer Imaging; 2022 Jul; 22(1):36. PubMed ID: 35869521 [TBL] [Abstract][Full Text] [Related]
5. Comparison of Zamboglou C; Drendel V; Jilg CA; Rischke HC; Beck TI; Schultze-Seemann W; Krauss T; Mix M; Schiller F; Wetterauer U; Werner M; Langer M; Bock M; Meyer PT; Grosu AL Theranostics; 2017; 7(1):228-237. PubMed ID: 28042330 [TBL] [Abstract][Full Text] [Related]
7. MRI versus ⁶⁸Ga-PSMA PET/CT for gross tumour volume delineation in radiation treatment planning of primary prostate cancer. Zamboglou C; Wieser G; Hennies S; Rempel I; Kirste S; Soschynski M; Rischke HC; Fechter T; Jilg CA; Langer M; Meyer PT; Bock M; Grosu AL Eur J Nucl Med Mol Imaging; 2016 May; 43(5):889-897. PubMed ID: 26592938 [TBL] [Abstract][Full Text] [Related]
8. Validation of different PSMA-PET/CT-based contouring techniques for intraprostatic tumor definition using histopathology as standard of reference. Zamboglou C; Fassbender TF; Steffan L; Schiller F; Fechter T; Carles M; Kiefer S; Rischke HC; Reichel K; Schmidt-Hegemann NS; Ilhan H; Chirindel AF; Nicolas G; Henkenberens C; Derlin T; Bronsert P; Mavroidis P; Chen RC; Meyer PT; Ruf J; Grosu AL Radiother Oncol; 2019 Dec; 141():208-213. PubMed ID: 31431386 [TBL] [Abstract][Full Text] [Related]
9. Optimal Draulans C; De Roover R; van der Heide UA; Kerkmeijer L; Smeenk RJ; Pos F; Vogel WV; Nagarajah J; Janssen M; Isebaert S; Maes F; Mai C; Oyen R; Joniau S; Kunze-Busch M; Goffin K; Haustermans K Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1211-1218. PubMed ID: 33025093 [TBL] [Abstract][Full Text] [Related]
10. Predictive significance of intraprostatic volumetric parameters derived from early and standard time 68Ga-PSMA PET/CT images in newly diagnosed prostate cancer patients. Erdogan EB; Tekce E; Koca S; Aslan N; Toluk O; Aydin M Nucl Med Commun; 2024 Jul; 45(7):629-641. PubMed ID: 38835183 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Manual and Semi-Automatic [ Spohn SKB; Kramer M; Kiefer S; Bronsert P; Sigle A; Schultze-Seemann W; Jilg CA; Sprave T; Ceci L; Fassbender TF; Nicolay NH; Ruf J; Grosu AL; Zamboglou C Front Oncol; 2020; 10():600690. PubMed ID: 33365271 [TBL] [Abstract][Full Text] [Related]
19. 68Ga-PSMA-I&T-PET/CT interobserver and intraobserver agreement for prostate cancer: a lesion based and subregional comparison study among observers with different levels of experience. Soyluoglu S; Korkmaz U; Ozdemir B; Ustun F; Durmus-Altun G Nucl Med Commun; 2021 Oct; 42(10):1122-1129. PubMed ID: 34001829 [TBL] [Abstract][Full Text] [Related]